For research use only. Not for therapeutic Use.
CSRM617 hydrochloride(Cat No.:I042959)is a small molecule inhibitor that selectively targets the protein kinase B (AKT) signaling pathway, which plays a key role in cell growth, survival, and metabolism. By inhibiting AKT, CSRM617 hydrochloride has potential therapeutic applications in cancer treatment, as it can disrupt the aberrant signaling that contributes to tumor growth and resistance to chemotherapy. This compound is being explored in preclinical studies to assess its effectiveness in treating various cancers, particularly those with mutations or overexpression of AKT. CSRM617 hydrochloride may also have applications in metabolic and inflammatory diseases.
CAS Number | 1353749-74-2 |
Synonyms | 2-amino-3-hydroxy-N-[(E)-(2,3,4-trihydroxyphenyl)methylideneamino]propanamide;hydrochloride |
Molecular Formula | C10H14ClN3O5 |
Purity | ≥95% |
IUPAC Name | 2-amino-3-hydroxy-N-[(2,3,4-trihydroxyphenyl)methylideneamino]propanamide;hydrochloride |
InChI | InChI=1S/C10H13N3O5.ClH/c11-6(4-14)10(18)13-12-3-5-1-2-7(15)9(17)8(5)16;/h1-3,6,14-17H,4,11H2,(H,13,18);1H |
InChIKey | YBUPSOQAGSOATG-UHFFFAOYSA-N |
SMILES | C1=CC(=C(C(=C1C=NNC(=O)C(CO)N)O)O)O.Cl |